MURPHY ANDREW J (EVP Research) reported 1 transaction at REGENERON PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/11/2025ACC: 0001796226-25-000009
Officer· EVP Research
Since Dec 2019
-4.23K
Net shares
Net seller
$2.97M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.23K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.23K
Price / share
$701.51
Trade value
$2.97M
% of position
8.1%
12/9/2025
52.06K→47.83K
Total
Net shares
−4.23K
Net value
-$2.97M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2025 | F · Tax Withholding | −4.23K | $701.51 | $2.97M | 8.1% | 52.06K | 47.83K |
| Total | −4.23K | -$2.97M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.38K
Total
4.38K indirect4.38K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.38K | Indirect |
| Total | 4.38K | 4.38K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported